
Struggling Pharma Stocks: Is Novo Nordisk a Hidden Gem?
Novo Nordisk A/S is a leading player in the pharmaceutical sector, particularly strong in diabetes care. Despite a 32.48% stock decline last year, experts predict a 45.6% upside potential. The company reported a significant 25% increase in sales for 2024, totaling $40.6